What does MedeAnalytics do?
MedeAnalytics is a leader in healthcare analytics, providing innovative solutions that enable measurable impact for healthcare payers and providers.
What is truven data?
Truven Health (IBM) MarketScan Databases: These are a set of databases of insurance claims compiled from health insurers, large employers, and government programs. Truven reports that, since 1995, the claims of 240 million unique individuals have been incorporated into the databases.
Is Innovaccer a product based company?
Innovaccer Inc. is a Silicon Valley-based digital healthcare company, founded by Abhinav Shashank, Kanav Hasija, and Sandeep Gupta that provides physician practices, hospitals, health systems, and other healthcare providers with different digital products….Innovaccer.
| Industry | Digital Healthcare |
|---|---|
| Website | www.innovaccer.com |
Where is Innovaccer based?
San Francisco
Innovaccer is based in San Francisco with offices around the United States and Asia.
Who owns truven?
IBM Corporation
IBM Corporation acquired Truven on February 18, 2016, and merged it with IBM’s Watson Health unit.
Who owns Truven Health Analytics?
Who owns Truven Health Analytics? IBM acquired Truven Health Analytics in 2016 for $2.6 billion.
Is Innovaccer a service based company?
Innovaccer Inc. is a Silicon Valley-based digital healthcare company, founded by Abhinav Shashank, Kanav Hasija, and Sandeep Gupta that provides physician practices, hospitals, health systems, and other healthcare providers with different digital products.
Should I join Innovaccer?
Is Innovaccer a good company to work for? Innovaccer has an overall rating of 3.7 out of 5, based on over 495 reviews left anonymously by employees. 72% of employees would recommend working at Innovaccer to a friend and 74% have a positive outlook for the business.
When did IBM buy truven?
IBM Corporation acquired Truven on February 18, 2016, and merged it with IBM’s Watson Health unit.
What is IBM MicroMedex?
IBM Micromedex (formerly MicroMedex Health) enables searching across a suite of drug information databases, covering drug administration, adverse effects, clinical applications, contraindications, dosage, indications, interactions, over-dosage, pharmacology, precautions, product/substance identification, toxicity.
Why did IBM sell Watson Health?
In April of 2019 IBM halted the development and sales of its Watson AI drug discovery tools, citing disappointing sales, according to an earlier EnterpriseAI story. With the move, the company shifted the focus of its Watson Health offering to “clinical development” as it readjusted its market strategy.
Will IBM sell Watson Health?
IBM has reached a deal to sell the healthcare data and analytics assets from its Watson Health business to investment firm Francisco Partners, the companies announced Friday.